Jump to content


Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Photo

Outcome of a glucocorticoid (GC) discontinuation regimen in patients with inactive systemic sclerosis.

steroids

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 29 September 2016 - 11:01 AM

Outcome of a glucocorticoid (GC) discontinuation regimen in patients with inactive systemic sclerosis.

 

Disability as assessed by Health Assessment Questionnaire Disability Index (HAQ–DI) was the leading factor hindering GC discontinuation, as a low HAQ–DI score can identify candidates for GC discontinuation. PubMed, Clin Rheumatol, 2016 Aug;35(8):1985-91. (Also see Glucocorticoids, Steroids (Prednisone) Warnings for Scleroderma)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)